ACC.24 Clinical Trials Recap, with Deepak Bhatt, MD, MPH, MBA
Deepak Bhatt, MD, MPH, MBA, provides a recap of top trials and new data from the American College of Cardiology's 2024 Annual Scientific Session.
Source: hcplive.com
Preserved Ejection News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Preserved Ejection. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Preserved Ejection Today - Breaking & Trending Today
Beta-blockers show no benefit for heart attack patients with normal heart function
The REDUCE-AMI trial found that long-term beta-blocker therapy does not reduce mortality risk in acute myocardial infarction patients with preserved left ventricular ejection fraction compared to no beta-blocker treatment.
Source: news-medical.net
Unnecessary use of beta-blockers after a hear
<p><strong>Half of all patients discharged from hospital after a heart attack are treated with beta-blockers unnecessarily. This is according to a new study published in the New England Journal of Medicine. "I am convinced that this will influence future practice", says Tomas Jernberg, Professor at Karolinska Institutet and lead researcher of the study.</strong></p>
Source: eurekalert.org
Unnecessary Use Of Beta-blockers After Heart Attack
Half of all patients discharged from hospital after a heart attack are treated with beta-blockers unnecessarily. This is according to a new study
Source: nationaltribune.com.au
Top 5 Pharmacy Times Heart Failure Articles of 2023
From newsworthy moments to groundbreaking research, these were the most-read heart failure-related articles on Pharmacy Times in 2023.
Source: pharmacytimes.com